Bisphosphonate-related osteonecrosis of the jaws (Bronj)

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 18, Issue 5, 2013, Pages

  Beninati, Francesco ^a   Pruneti, Riccardo ^a   Ficarra, Giuseppe ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bisphosphonates; Follow up; Osteonecrosis; Treatment

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLINDAMYCIN; IBUPROFEN; NIMESULIDE; TRAMADOL;

ADULT; AGED; ARTICLE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE FRACTURE; MAXILLA RESECTION; MULTIPLE MYELOMA; ORAL FISTULA; OROANTRAL FISTULA; OSTEOCUTANEOUS FLAP; OSTEOLYSIS; OSTEOTOMY; PAIN; PARESTHESIA; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SKIN FISTULA; TOOTH EXTRACTION; TRISMUS;

AGED; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 84883370023     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.18076     Document Type: Article

References (23)

1. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2007;65:369-76.
2. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw-2009 Update. Aust Endod J. 2009;35:119-30.
3. Silverman SL, Landesberg R. Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review. Am J of Med. 2009;122:S33-S45.
4. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415-23.
5. Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. 2009;27:5356-62.
6. Filleul O, Crompot E, Saussez E. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2400 patient cases. J Cancer Res Clin Oncol. 2010;136:1117-24.
7. Favia G, Pilolli GP, Maiorano E. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol. 2009;36:2780-7.
8. Rodan GA, Fleisch HA. Bosphosphonates: mechanisms of action. J Clin Invest. 1996;97:2692-6.
9. Wang, J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. Journal of Oral and Maxillofacial Surgery. 2003;61:1104-7.
10. Marx, RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of Oral and Maxillofacial Surgery. 2003;61:1115-7.
11. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonateinduced exposed bone (osteonecrosis\osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg. 2005;63:1567-75.
12. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005;104:83-93.
13. Pires FR, Miranda A, Cardoso ES, Cardoso AS, Fregnani ER, Pereira CM et al. Oral avascular bone necrosis associated with chemotherapy and bisphosphonate therapy. Oral Dis 2005;11:365-9.
14. Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P et al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 2005;32:1123-8.
15. Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-61.
16. Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-61.
17. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007;41:318-20.
18. Ficarra G, Beninati F. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head Neck Pathol. 2007;1:132-40.
19. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479-91.
20. Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 2009;67:75-84.
21. Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol. 2009;30:390-5.
22. Treister NS, Friedland B, Woo SB. Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:753-64.
23. Williamson RA. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg. 2010;39:251-5.